|
|
Volumn 312, Issue 7030, 1996, Pages 577-
|
|
Third generation oral contraceptives. Postmarketing surveillance does not catch all adverse events.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ORAL CONTRACEPTIVE AGENT;
CHEMICALLY INDUCED DISORDER;
FEMALE;
HUMAN;
NOTE;
POSTMARKETING SURVEILLANCE;
THROMBOEMBOLISM;
CONTRACEPTIVES, ORAL, SYNTHETIC;
FEMALE;
HUMANS;
PRODUCT SURVEILLANCE, POSTMARKETING;
THROMBOEMBOLISM;
MLCS;
MLOWN;
|
|
EID: 0030562594
PISSN: 09598138
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.312.7030.577 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
